Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Ketamine as an alternative treatment for treatment-resistant depression.

Dowben JS, Grant JS, Keltner NL.

Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30. Review. No abstract available.

PMID:
23293991
2.

Ketamine for the treatment of depression.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2013 Jan;51(1):11-4.

PMID:
23413455
3.

Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.

Blier P.

Biol Psychiatry. 2013 Aug 15;74(4):238-9. doi: 10.1016/j.biopsych.2013.05.029. No abstract available.

PMID:
23885752
4.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
5.

[Ketamine for treatment of acute depression].

Hjerrild S, Bjerre J, Pedersen RH, Videbech P.

Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Review. Danish.

PMID:
24011203
6.

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.

Correll GE, Futter GE.

Pain Med. 2006 Jan-Feb;7(1):92-5. No abstract available.

7.

Intravenous ketamine therapy in a patient with a treatment-resistant major depression.

Liebrenz M, Borgeat A, Leisinger R, Stohler R.

Swiss Med Wkly. 2007 Apr 21;137(15-16):234-6.

8.

Intravenous ketamine for treatment-resistant major depressive disorder.

Covvey JR, Crawford AN, Lowe DK.

Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20. Review.

PMID:
22190250
9.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

10.

Ketamine for treatment-resistant depression: ready or not for clinical use?

Rush AJ.

Am J Psychiatry. 2013 Oct;170(10):1079-81. doi: 10.1176/appi.ajp.2013.13081034. No abstract available.

PMID:
23982324
11.

Ketamine followed by memantine for the treatment of major depression.

Kollmar R, Markovic K, Thürauf N, Schmitt H, Kornhuber J.

Aust N Z J Psychiatry. 2008 Feb;42(2):170. doi: 10.1080/00048670701787628. No abstract available.

PMID:
18197514
12.

A word to the wise about ketamine.

Schatzberg AF.

Am J Psychiatry. 2014 Mar;171(3):262-4. doi: 10.1176/appi.ajp.2014.13101434. No abstract available.

PMID:
24585328
13.

Electroconvulsive therapy is a standard treatment; ketamine is not (yet).

Kellner CH, Greenberg RM, Ahle GM, Liebman LS.

Am J Psychiatry. 2014 Jul;171(7):796. doi: 10.1176/appi.ajp.2014.14030354. No abstract available.

PMID:
24980176
14.

Mechanism of action of ketamine.

Stahl SM.

CNS Spectr. 2013 Aug;18(4):171-4. doi: 10.1017/S109285291300045X.

PMID:
23866089
15.

N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.

Krystal JH.

Arch Gen Psychiatry. 2010 Nov;67(11):1110-1. doi: 10.1001/archgenpsychiatry.2010.138. No abstract available.

PMID:
21041611
16.

Response to Zhang and Ho: Addressing Ketamine's Use in Depression.

Newport DJ, Nemeroff CB.

Am J Psychiatry. 2016 Apr 1;173(4):431-2. doi: 10.1176/appi.ajp.2016.15111401r. No abstract available.

PMID:
27035536
17.

[Ketamine--a new treatment option for therapy-resistant depression].

Köhler S, Betzler F.

Fortschr Neurol Psychiatr. 2015 Feb;83(2):91-7. doi: 10.1055/s-0034-1398967. Epub 2015 Feb 27. Review. German.

PMID:
25723773
18.

Clinical predictors of ketamine response in treatment-resistant major depression.

Niciu MJ, Luckenbaugh DA, Ionescu DF, Guevara S, Machado-Vieira R, Richards EM, Brutsche NE, Nolan NM, Zarate CA Jr.

J Clin Psychiatry. 2014 May;75(5):e417-23. doi: 10.4088/JCP.13m08698.

19.

Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.

Zhang MW, Ho R.

Am J Psychiatry. 2016 Apr 1;173(4):431. doi: 10.1176/appi.ajp.2016.15111401. No abstract available.

PMID:
27035535
20.

Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.

Kantrowitz JT, Halberstam B, Gangwisch J.

J Clin Psychiatry. 2015 Jun;76(6):737-8. doi: 10.4088/JCP.14l09527. No abstract available.

PMID:
26132675
Items per page

Supplemental Content

Write to the Help Desk